MONTGOMERYVILLE, Pa., May 18, 2011 /PRNewswire/ -- With XTRAC® Excimer Laser (www.XTRACLaser.com) treatments, psoriasis patients can say goodbye to the red, dry patches of scaly, thickened skin they have been covering up all winter. Developed by PhotoMedex, Inc. (NASDAQ: PHMD), an innovator of medical devices, the XTRAC laser offers new hope to the 7.5 million Americans suffering from this embarrassing and socially isolating disease. Broad coverage of the XTRAC treatments for psoriasis by Medicare and all major insurance companies now provides greater access to care for psoriasis sufferers who have spent their lives covering up the embarrassing symptoms of psoriasis.
According to a report from the National Psoriasis Foundation(1), 73 percent of psoriasis sufferers reported feeling self-conscious about their psoriasis with, 68 percent reporting it as embarrassing and 54 percent stating their psoriasis was disfiguring. For the first time, those who suffer from these physical and emotional side effects can get relief with the XTRAC Laser. The XTRAC laser is the only clinically proven, FDA-cleared dermatology excimer laser with independent safety and quality certifications. It provides targeted phototherapy treatment for psoriasis, offering safe, effective and lasting results.
Depending on the extent and severity of the patient's psoriasis, each procedure requires only about five minutes. Noticeable improvements are usually seen within three or four treatments, with many patients seeing 75 percent or more improvement in as few as six to 10 treatments and average remission periods lasting 4-6 months, often longer. The laser is effective even in areas that are difficult to treat, such as elbows, knees and the scalp. XTRAC Laser treatments have been successful with psoriasis that has spread across as much as 20 percent of body surface area.
While the ultraviolet rays of the sun can help some psoriasis patients, summer comes with its own set of challenges for others. Here are a few tips for caring for psoriasis during the summer from Dr. Bruce Katz, director of the Juva Skin and Laser Center in New York City.
"Patients can avoid dealing with a lot of these challenges by starting the XTRAC laser treatments now," said Dr. Katz. "Not only will patients be able to feel comfortable wearing summer apparel like shorts and bathing suits, they won't have to worry about dealing with flare-ups all summer long."
What makes the XTRAC laser so important in relieving psoriasis is that it avoids the often dangerous consequences of other treatment approaches, such as topical steroids, full-body UVB exposure, systemic medications or biologics. Those techniques may produce a range of effects, from premature aging of healthy skin to the risk of malignancies and tuberculosis. The safe and effective XTRAC has not been associated with any of those kinds of side effects, because the XTRAC excimer laser uses a precisely focused beam of ultraviolet light only on the affected skin area, avoiding exposure to healthy skin.
For more information about the XTRAC excimer laser, visit www.XTRACLaser.com. The website features a TeleCare Center where patients can speak directly with highly experienced clinical specialists about the XTRAC laser therapy. The specialists also will assist those interested in making appointments with physicians experienced in providing XTRAC laser treatments.
PhotoMedex is a leader in the development, manufacturing, and global marketing of dermatology products and techniques focused on advancing cost-effective technologies that provide patients with better outcomes and a higher quality of life. The company is uniquely positioned to research and commercialize therapies that innovatively combine both medical devices and science-based aesthetic products. Medical devices include the XTRAC® Excimer Laser for the treatment of skin diseases like psoriasis and vitiligo and the Omnilux™ non-laser light-emitting diodes (LED) for the treatment of clinical and aesthetic dermatological conditions, including acne, photodamage, skin rejuvenation, and wound healing. Adding to these therapies, the company markets a broad range of specialty skin-care products based upon its clinically proven DNA + Copper Peptide technologies for skin heath and Copper Peptide Complexes for hair and wound care, including its NEOVA®, DNA Damage Control™, Tricomin® and Graftcyte® brands. PhotoMedex sells directly to dermatologists; plastic and cosmetic surgeons, spas; salons; and, through strategic partners, in the consumer market. In addition, the company manufactures and distributes surgical lasers and disposables to hospitals and surgery centers for procedures in urology, gynecology, orthopedics and other surgical specialties. For more information please visit www.photomedex.com.
(1) Report on the Psycho-Social Impacts of Psoriasis – National Psoriasis Foundation http://www.psoriasis.org/NetCommunity/Document.Doc?id=619
|SOURCE PhotoMedex, Inc.|
Copyright©2010 PR Newswire.
All rights reserved